Live Chat ×
Skip to main content


Evaluated by: David B. Kaminsky, M.D., FIAC, May 21, 2017
Original release date: November 17, 2017
Access to this course expires on: May 19, 2020

Peter A. Humphrey, M.D., Ph.D.

Learning Objectives:
  • To be aware of the most common benign mimickers of prostate cancer 
  • To understand the histomorphological effects of androgen deprivation therapy on adenocarcinoma of the prostate 
  • To be able to address the differential diagnosis of urothelial carcinoma versus adenocarcinoma of the prostate
  • To be cognizant of the histomorphological characteristics of deceptively benign prostate cancers
  • To recognize the histological presentations of ductal adenocarcinoma of the prostate
  • To know the best approach in immunophenotyping of metastatic adenocarcinoma of the prostate 
  • To appreciate the features of lymphoma when discovered in the prostate

blog comments powered by Disqus